Cerapedics Inc. Email Format
Biotechnology ResearchColorado, United States51-200 Employees
Cerapedics is a mid-sized biotechnology company focused on orthopedics, aiming to improve bone repair so patients can return to daily life more quickly. Its bone graft products are used in spine, orthopedics, trauma, and interventional procedures worldwide, supporting more than four million procedures each year. The company offers two FDA-approved bone grafts built on its proprietary P-15 Osteogenic Cell Binding Peptide technology: PearlMatrix Bone Graft for major lumbar interbody approaches and i-FACTOR Bone Graft for single-level cervical fusion. Headquartered in Westminster, Colorado, Cerapedics operates as a global commercial-stage participant in the orthobiologics industry. Its products are used by surgeons and healthcare facilities involved in bone repair, providing peptide-enhanced grafts intended to support faster and higher rates of bone healing. In October 2023, the company announced long-term follow-up data from a pivotal IDE study of i-FACTOR, reflecting ongoing clinical validation of its lead graft.